Sodium-Glucose Cotransporter 2 Inhibitors for Metabolic Dysfunction-Associated Steatohepatitis [0.03%]
钠-葡萄糖共转运蛋白2抑制剂治疗代谢失调相关性肝炎
Jiayang Lin,Yan Huang,Bingyan Xu et al.
Jiayang Lin et al.
MASH denotes metabolic dysfunction-associated steatohepatitis. MASH improvement was defined as a decrease in the non-alcoholic fatty liver disease activity score (NAS) of ≥ 2 points or NAS ≤ 3 at week 48 after treatment, with no worsening...
Beyond GLP-1 [0.03%]
GLP-1以外的功效与机制
Zachary Bloomgarden
Zachary Bloomgarden
Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long-Term Follow-Up [0.03%]
糖尿病患者DCB治疗后的长期随访中，胰岛素或达格列净可能改善罪犯血管相关的INOCA或与微循环功能障碍有关的情况
Wei You,Xianglian Ma,Yan Xu et al.
Wei You et al.
Background: This study aims to investigate the relationship between risk factors and IRA-related microcirculatory dysfunction, as well as its pharmacological intervention in the context of STEMI treatment using DCB over a...
Multicenter Study
Journal of diabetes. 2026 Feb;18(2):e70197. DOI:10.1111/1753-0407.70197 2026
The Predictive Value of Hemoglobin Glycation Index and Clonal Hematopoiesis of Indeterminate Potential Among AMI Patients-A Prospective Registry Study [0.03%]
糖化指数和不确定克隆造血在急性心肌梗死患者中的预测价值——一项前瞻性登记研究
Linghan Xue,Wenhao Dong,Jiannan Li et al.
Linghan Xue et al.
Aims: The objective of this research is to explore the combined effect of hemoglobin glycation index (HGI) and clonal hematopoiesis of indeterminate potential (CHIP) on all-cause mortality among patients diagnosed with ac...
Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression [0.03%]
关于二甲双胍作为系统性治疗以预防糖尿病视网膜病变进展的德尔菲共识
Richard C O&#x;Brien,Khalifa Abdallah,Xuehong Dong et al.
Richard C O&#x;Brien et al.
Background: Diabetic retinopathy remains a leading cause of preventable blindness worldwide, yet screening and management practices vary widely. Evidence suggests that systemic therapies, including fenofibrate, may slow d...
Who Wins the Battle Against Obesity? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide [0.03%]
谁能在对抗肥胖的战役中胜出？ tirzepatide与semaglutide比较的网状meta分析
Julia C Bernardi,Deivyd V S Cavalcante,Ramon Huntermann et al.
Julia C Bernardi et al.
Introduction: Pharmacological therapies are recommended for individuals with obesity. Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), and tirzepatide, a dual glucose-dependent insulinotropic polypeptide a...
Blood Glucose and Hemoglobin A1c Trends Pre-, During, and Post-COVID-19 Pandemic in an Urban Population [0.03%]
新冠疫情对城市人群血糖和糖化血红蛋白的影响研究
Wayne Shih,Roham Hadidchi,Ekram Ali et al.
Wayne Shih et al.
Algorithm-Based Common Microcirculatory Framework for Monitoring and Visualizing the Integrated Pancreatic Microcirculation in Type 2 Diabetes Mellitus Mice [0.03%]
一种基于算法的共同微循环框架用于监测和可视化2型糖尿病小鼠的胰腺微循环整合情况
Yuan Li,Yingyu Wang,Bing Wang et al.
Yuan Li et al.
Background: Recent research has challenged the viewpoint that pancreatic islets operate independently of surrounding exocrine tissues, revealing a bidirectional blood flow between the endocrine and exocrine pancreas. Howe...
Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey [0.03%]
墨西哥2型糖尿病与抑郁症状共病的患病率及危险因素：来自ENSAUNT 2022全国代表性调查的数据
Ankita Adhikari,Damith Chandrasenage,Suman Prinjha et al.
Ankita Adhikari et al.
Aims: Type 2 Diabetes Mellitus (T2DM) and depression are major public health challenges, with Mexico ranking among the countries with the highest prevalence of both. Research into the bidirectional relationship between th...